Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Total Assets (Quarterly) : 885.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 885.54M |
| March 31, 2026 | 697.46M |
| December 31, 2025 | 669.89M |
| September 30, 2025 | 701.69M |
| June 30, 2025 | 718.01M |
| March 31, 2025 | 742.13M |
| December 31, 2024 | 746.83M |
| September 30, 2024 | 603.86M |
| June 30, 2024 | 614.63M |
| March 31, 2024 | 629.28M |
| December 31, 2023 | 358.17M |
| September 30, 2023 | 330.02M |
| June 30, 2023 | 320.47M |
| March 31, 2023 | 239.86M |
| December 31, 2022 | 247.93M |
| September 30, 2022 | 282.17M |
| June 30, 2022 | 310.51M |
| March 31, 2022 | 348.30M |
| December 31, 2021 | 347.70M |
| September 30, 2021 | 373.18M |
| June 30, 2021 | 404.23M |
| Date | Value |
|---|---|
| March 31, 2021 | 298.07M |
| December 31, 2020 | 325.51M |
| September 30, 2020 | 217.32M |
| June 30, 2020 | 224.98M |
| March 31, 2020 | 134.90M |
| December 31, 2019 | 156.19M |
| September 30, 2019 | 154.63M |
| June 30, 2019 | 148.10M |
| March 31, 2019 | 132.25M |
| December 31, 2018 | 139.47M |
| September 30, 2018 | 148.86M |
| June 30, 2018 | 137.47M |
| March 31, 2018 | 149.24M |
| December 31, 2017 | 163.73M |
| September 30, 2017 | 110.42M |
| June 30, 2017 | 70.48M |
| March 31, 2017 | 82.67M |
| December 31, 2016 | 93.99M |
| September 30, 2016 | 102.84M |
| June 30, 2016 | 24.52M |
| March 31, 2016 | 31.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 49.36B |
| Insmed, Inc. | 2.103B |
| Madrigal Pharmaceuticals, Inc. | 1.245B |
| AbbVie, Inc. | 135.12B |
| PTC Therapeutics, Inc. | 3.250B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 44.00M |
| Shareholders Equity (Quarterly) | 841.54M |
| Debt to Equity Ratio | 0.011 |
| Current Ratio | 21.71 |
| Net Debt Paydown Yield | 0.01% |